GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » YanAn Bicon Pharmaceutical Listed Co (SZSE:002411) » Definitions » Revenue

YanAn Bicon Pharmaceutical Listed Co (SZSE:002411) Revenue : ¥7,058 Mil (TTM As of Mar. 2023)


View and export this data going back to 2010. Start your Free Trial

What is YanAn Bicon Pharmaceutical Listed Co Revenue?

YanAn Bicon Pharmaceutical Listed Co's revenue for the three months ended in Mar. 2023 was ¥1,211 Mil. Its revenue for the trailing twelve months (TTM) ended in Mar. 2023 was ¥7,058 Mil. YanAn Bicon Pharmaceutical Listed Co's Revenue per Share for the three months ended in Mar. 2023 was ¥0.79. Its Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2023 was ¥4.42.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.


YanAn Bicon Pharmaceutical Listed Co Revenue Historical Data

The historical data trend for YanAn Bicon Pharmaceutical Listed Co's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

YanAn Bicon Pharmaceutical Listed Co Revenue Chart

YanAn Bicon Pharmaceutical Listed Co Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8,446.81 9,329.25 6,939.53 7,663.19 8,106.28

YanAn Bicon Pharmaceutical Listed Co Quarterly Data
Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23
Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,259.44 1,733.17 2,177.81 1,935.86 1,210.90

Competitive Comparison of YanAn Bicon Pharmaceutical Listed Co's Revenue

For the Chemicals subindustry, YanAn Bicon Pharmaceutical Listed Co's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


YanAn Bicon Pharmaceutical Listed Co's Revenue Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, YanAn Bicon Pharmaceutical Listed Co's Revenue distribution charts can be found below:

* The bar in red indicates where YanAn Bicon Pharmaceutical Listed Co's Revenue falls into.



YanAn Bicon Pharmaceutical Listed Co Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Mar. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥7,058 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


YanAn Bicon Pharmaceutical Listed Co  (SZSE:002411) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


YanAn Bicon Pharmaceutical Listed Co Revenue Related Terms

Thank you for viewing the detailed overview of YanAn Bicon Pharmaceutical Listed Co's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


YanAn Bicon Pharmaceutical Listed Co (SZSE:002411) Business Description

Traded in Other Exchanges
N/A
Address
No. 6 Jinye 1st Road, 39th Floor, Yongli International Financial Center, Yanta District, Shaanxi Province, Xian, CHN, 710065
YanAn Bicon Pharmaceutical Listed Co is a Chinese company principally involved in the research, development, manufacture and distribution of pharmaceutical intermediates, pesticide intermediates and fertilizers. Some of its products include Cough series, Nourishing blood tonic series, benzaldehyde and other chemicals.
Executives
Tang Nuo Supervisors
Zhou Xin Ji Director
Gu Xiao Jia Director
Zhu Jian Jun Executives
Liu Yu Ming Executives
Huang Hui Director
Chen Bing Directors, executives
Guo Jin Huang Directors, executives
Zhou Hai Feng Director
Wu Xiao Qiang Director
Zhang Jin Shan Executives
Xia Jian Hua Directors, executives
Yang Xiao Bing Supervisors
Xu Bing Executives
Yang De Xin Director

YanAn Bicon Pharmaceutical Listed Co (SZSE:002411) Headlines

No Headlines